Compare PLNT & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | MMED |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2015 | 2026 |
| Metric | PLNT | MMED |
|---|---|---|
| Price | $55.00 | $16.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $107.46 | $22.56 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,324,144,000.00 | N/A |
| Revenue This Year | $19.22 | $15.99 |
| Revenue Next Year | $11.66 | $10.00 |
| P/E Ratio | $38.47 | ★ N/A |
| Revenue Growth | ★ 12.06 | N/A |
| 52 Week Low | $37.03 | $10.65 |
| 52 Week High | $114.47 | $17.86 |
| Indicator | PLNT | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 66.74 |
| Support Level | $49.50 | $14.70 |
| Resistance Level | $75.96 | N/A |
| Average True Range (ATR) | 1.62 | 0.85 |
| MACD | 0.45 | 0.12 |
| Stochastic Oscillator | 74.82 | 78.65 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.